Publication Cover
Hemoglobin
international journal for hemoglobin research
Volume 28, 2004 - Issue 4
46
Views
13
CrossRef citations to date
0
Altmetric
Original Article

Study on Molecular Epidemiology of the α‐Thalassemias in Liuzhou City, Guangxi Autonomous Region, China

, , , , , , & show all
Pages 325-333 | Received 09 Mar 2004, Accepted 26 Apr 2004, Published online: 24 Aug 2009
 

Abstract

Guangxi is one of the provinces of Southern China with the highest incidence of α‐thalassemia (thal). Liuzhou is the second biggest city in Guangxi. To find out the incidence of the various α‐thal genotypes, and their distribution in the Liuzhou area, an F820 Blood Cell Analysis System was used to measure the parameters of red blood cells. A SPIFE Rapid Auto‐Electrophoresis System was used to analyze the normal and abnormal hemoglobins (Hbs). Multiplex polymerase chain reaction (mPCR) was used to detect the α‐globin genotypes. Thirty‐two (2.05%) out of 7805 young couples undergoing pre‐marriage counseling, were diagnosed as having an Hb H (β4) disease. The study of 1228 cord blood samples revealed 138 newborn children carrying an α‐thal determinant with nine different genotypes, thus making the total incidence of α‐thal 11.24%. Among 185 cases of Hb H, 119 (64.1%) were confirmed as being deletional, and 66 cases (35.7%) nondeletional types. The severity of the Hb H diseases could be classified in the following order: αCSα/– –SEAConstant Springα/– –Southeast Asia); α− 4.2/– –SEA; α− 3.7/– –SEA. Ten cases of α‐thal determinants were found in combination with β‐thal. The mPCR technique can detect all kinds of combinations of the three common large deletions (– –SEA, α− 4.2 and α− 3.7) accurately and conveniently.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.